January 20, 2022
Dr Dima El-Sharkawi presents a podcast on the Guidelines on diagnosis and management of Waldenström macroglobulinaemia
Dr El-Sharkawi discusses the guideline in three main parts:
1) Presentation of diagnosis of Waldenström macroglobulinaemia
2) Treatment of Waldenström macroglobulinaemia
3) Common complications of Waldenström macroglobulinaemia
Dr Dima El-Sharkawi is a Consultant Haematologist and part of the haematological malignancy diagnostic services at the Royal Marsden NHS Foundation Trust. She is also a Trustee for the UK Charity for Waldenström macroglobulinaemia (WMUK). Dr El-Sharkawi's special interests are in CLL, rare leukaemias and lymphomas including Waldenström macroglobulinaemia.
December 2, 2021
Dr Christopher Fox presents a podcast on the Guidelines for the management of mature T- and natural killer-cell lymphomas (excluding cutaneous T-cell lymphoma).
Dr Fox discusses the guideline in three main parts:
1) Background and context on this diesease area; reflects on the progress that has been made over the past decade.
2) General recommendations from the guideline.
3) Specific disease areas where some progress has been made in clinical treatments and in other disease areas where more work is needed.
Dr Christopher Fox is a consultant Haematologist at the Nottingham University Hospital and Honourary Associate Professor at the University of Nottingham. He is the Chair of the UK National Cancer Research Institute Aggressive Cancer Study Group (NCRI). Dr Fox's main background and interest are in the field of T-cell Lymphoma including being a member of the international T-cell project.
October 27, 2021
Prof Steve Schey presents a podcast on the Guideline on The management of Castleman disease.
Prof Schey discusses management and best outcome treatments of Castleman disease.
Professor Steve Schey is a Consultant Haematologist and Head of Myeloma Services at Kings College Hospital, London. He is one of the founding members of the Castleman Disease Collaborative Network. He is a trustee of the lymphoma research trust. He is Chairman of the NCRI Myeloma Clinical Trials Committee. He has been Chief Investigator and Co-investigator for a large number of clinical trials. His research interests are in multiple myeloma and the bone marrow microenvironment as potential novel therapeutic targets, and haemopoietic stem cell transplantation
October 25, 2021
Dr Toby Eyre presents a short podcast on the Good Practice Paper Richter transformation of chronic lymphocytic leukaemia
Dr Eyre discusses the following:
1) Diagnostic work up of richter transformation
2) Current treatments available in this disorder
3) Future developments and ongoing trials
Dr Toby Eyre is a Consultant Haematologist and honorary senior lecturer at Oxford University Hospitals NHS Foundation Trust, specialising in the management of lymphoid malignancies. He is considered a national expert in the management of patients with lymphoma and patients with chronic lymphocytic leukaemia. He is heavy involved in clinical trials of richter syndrome in the UK. Some of his special interests include acute myeloid leukaemia, chronic myeloid leukaemia, hodgkin lymphoma and myeloma. Dr Eyre holds the position of secretary on the BSH Haematology Oncology Task Force.
October 7, 2021
Dr Suzy Morton presents a short podcast on the Good Practice Paper: Cytomegalovirus serological testing in potential allogeneic haematopoietic stem cell transplant recipients.
Dr Morton discusses the following:
1) The background and importance of cytomegalovirus serological testing
2) Explaining the recommendations
3) A short summary of the importance on key messages from this good practice paper
Dr Suzy Morton is a Consultant in clinical haematology and blood transfusion at the Queen Elizabeth Hospital, University Hospitals Birmingham and NHS Blood and Transplant. She is the transfusion representative on the West Midlands Haematology Specialty Training Committee and the educational lead for haematology SpRs at QEHB. Suzy is a transfusion representative on the BSH Education committee.
September 13, 2021
Dr Nilima Parry Jones introduces the podcast for the Good Practice Paper: Management of cardiovascular complications of bruton tyrosine kinase inhibitors (BTKi).
This good practice paper aims to help clinicians in recognising, understanding and appropriately managing cardiovascular complications of BTKi in order to optimise outcomes for patients.
The podcast is to take the form of a question and answer session between Dr Renata Walewska and Professor Gregory Lip.
Dr Nilima Parry-Jones is a Consultant Haematologist at the Aneurin Bevan Local Health, Wales and an executive member of the UK CLL Forum.
Dr Renata Walewska is a Consultant Haematologist at the Royal Bournemouth Hospital and Chair of the UK CLL Forum.
Professor Gregory Lip is Price-Evens Chair of Cardiovascular Medicine at the University of Liverpool and Director of the Liverpool Centre for Cardiovascular Science and the University of Liverpool and Liverpool Heart & Chest Hospital.
![Guidelines for the clinical and laboratory diagnosis of heritable platelet disorders in adults and children]()
August 27, 2021
Dr Keith Gomez presents a short podcast on the Guidelines for the clinical and laboratory diagnosis of heritable platelet disorders in adults and children.
Dr Gomez discusses the following:
1) Why we need this guideline now
2) Clinical assessment of heritable platelet disorders
3) Laboratory investigations of heritable platelet disorders
This guideline replaces the previous British Committee for Standards in Haematology guideline published in 2011 on laboratory diagnosis of heritable disorders of platelet function.1 The remit has been expanded to include clinical diagnosis and heritable thrombocytopenia under the overarching term heritable platelet disorder (HPD). Acquired disorders such as immune thrombocytopenia and drug-induced platelet dysfunction are not covered.
Also, Dr Gomez presented this guideline at the BSH ASM Guidelines session and this is available to view.
Dr Keith Gomez is the Chair of the BSH Haemostasis and Thrombosis Task Force and the President of the British Society of Haemostasis and Thrombosis. He currently is a Consultant Haematologist and Associate Professor in Haemostasis in the Haemophilia Centre and Thrombosis Unit at the Royal Free Hospital in London.
![Guideline on Management of sickle cell disease in pregnancy]()
August 20, 2021
Dr Eugene Oteng-Ntim presents a short podcast on the Guideline on Management of sickle cell disease in pregnancy.
The purpose of this guideline is to describe the management of sickle cell disease (SCD) in pregnancy in the UK.
It will cover the following: preconception screening and antenatal
Intrapartum and postnatal management of women with the condition.
It will not cover the management of women with sickle cell trait. Updates from the previous guideline1 include new information on pre-implantation genetic diagnosis (PGD), more comprehensive information on pre-conceptual screening and medication review, updated information on thromboprophylaxis, aspirin and vitamin D, changes to advice on antenatal care including frequency of ultrasonography (USS) scanning. It also includes reference to the most recent National Institute for Health and Clinical Excellence (NICE) and RCOG guidelines.
Also, this guideline was presented at the Guidelines Session at the ASM 2021 and the presentation can be found in our list of podcasts.
Dr Oteng-Ntim is a Consultant Obstetrician and Head of Obstetrics at Guy's and St Thomas NHS Trust Foundation. He is a Honorary Reader in Women's Health (KCL) and Honorary Associate Professor in Epidemiology and Population Health (LSHTM).
May 26, 2021
British Society Haematology Virtual Annual Scientific Meeting Guidelines Session 2021
General Haematology Presentations Question and Answer with Eugene Oteng-Ntim and Nick Cross; hosted by Jo Howard.
